265 related articles for article (PubMed ID: 29247752)
1. Insight into the dynamic of gadolinium based contrast agent (GBCA) hypersensitivity: Acquisition, persistence and disappearance.
Boehm I; Hungerbühler M; Heverhagen JT
Magn Reson Imaging; 2018 Jun; 49():1-3. PubMed ID: 29247752
[TBL] [Abstract][Full Text] [Related]
2. Breakthrough Hypersensitivity Reactions to Gadolinium-based Contrast Agents and Strategies to Decrease Subsequent Reaction Rates: A Systematic Review and Meta-Analysis.
Walker DT; Davenport MS; McGrath TA; McInnes MDF; Shankar T; Schieda N
Radiology; 2020 Aug; 296(2):312-321. PubMed ID: 32427558
[TBL] [Abstract][Full Text] [Related]
3. Subsequent MRI of pediatric patients after an adverse reaction to Gadolinium-based contrast agents.
Hojreh A; Peyrl A; Bundalo A; Szepfalusi Z
PLoS One; 2020; 15(4):e0230781. PubMed ID: 32243440
[TBL] [Abstract][Full Text] [Related]
4. Preventive Effect of Changing Contrast Media in Patients With A Prior Mild Immediate Hypersensitivity Reaction to Gadolinium-Based Contrast Agent.
Ryoo CH; Choi YH; Cheon JE; Yoon SH; Kang HR; Park SJ; Lee W
Invest Radiol; 2019 Oct; 54(10):633-637. PubMed ID: 31033674
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of Immediate Reactions to Injectable Gadolinium-based Contrast Agents.
Carr TF
Top Magn Reson Imaging; 2016 Dec; 25(6):265-268. PubMed ID: 27748716
[TBL] [Abstract][Full Text] [Related]
6. Preventing Allergic Reactions to Gadolinium-Based Contrast Agents.
Heshmatzadeh Behzadi A; Prince MR
Top Magn Reson Imaging; 2016 Dec; 25(6):275-279. PubMed ID: 27748715
[TBL] [Abstract][Full Text] [Related]
7. Empiric Switching of Gadolinium-Based Contrast Agents in Patients With History of Previous Immediate Hypersensitivity Reaction to GBCA: A Prospective Single-Center, Single-Arm Efficacy Trial.
Walker D; McGrath TA; Glikstein R; Chakraborty S; Blanchette C; Schieda N
Invest Radiol; 2021 Jun; 56(6):369-373. PubMed ID: 33337738
[TBL] [Abstract][Full Text] [Related]
8. Allergic-like Hypersensitivity Reactions to Gadolinium-based Contrast Agents: An 8-year Cohort Study of 154 539 Patients.
Ahn YH; Kang DY; Park SB; Kim HH; Kim HJ; Park GY; Yoon SH; Choi YH; Lee SY; Kang HR
Radiology; 2022 May; 303(2):329-336. PubMed ID: 35191737
[TBL] [Abstract][Full Text] [Related]
9. Hypersensitivity reactions to gadolinium-based contrast agents.
Fok JS; Smith WB
Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):241-246. PubMed ID: 28537933
[TBL] [Abstract][Full Text] [Related]
10. Delayed reaction following gadolinium-based contrast agent application.
Boehm I; Heverhagen JT
Magn Reson Imaging; 2018 Jul; 50():10-11. PubMed ID: 29540332
[TBL] [Abstract][Full Text] [Related]
11. Immediate Allergic Reactions to Gadolinium-based Contrast Agents: A Systematic Review and Meta-Analysis.
Behzadi AH; Zhao Y; Farooq Z; Prince MR
Radiology; 2018 Feb; 286(2):471-482. PubMed ID: 28846495
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity to gadolinium-based contrast.
Sáenz de Santa María R; Labella M; Bogas G; Doña I; Torres MJ
Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):300-306. PubMed ID: 37357781
[TBL] [Abstract][Full Text] [Related]
13. How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
Thomsen HS
Top Magn Reson Imaging; 2016 Dec; 25(6):269-274. PubMed ID: 27849654
[TBL] [Abstract][Full Text] [Related]
14. Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: from published evidence to a practical approach.
Tonolini M; Bianco R
Clin Ter; 2011; 162(6):591-4. PubMed ID: 22262334
[TBL] [Abstract][Full Text] [Related]
15. Adverse reactions to gadolinium contrast media: a review of 36 cases.
Murphy KJ; Brunberg JA; Cohan RH
AJR Am J Roentgenol; 1996 Oct; 167(4):847-9. PubMed ID: 8819369
[TBL] [Abstract][Full Text] [Related]
16. Allergic-like breakthrough reactions to gadolinium contrast agents after corticosteroid and antihistamine premedication.
Dillman JR; Ellis JH; Cohan RH; Strouse PJ; Jan SC
AJR Am J Roentgenol; 2008 Jan; 190(1):187-90. PubMed ID: 18094310
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium-Based Contrast Agents: Associated Adverse Reactions.
Ramalho M; Ramalho J
Magn Reson Imaging Clin N Am; 2017 Nov; 25(4):755-764. PubMed ID: 28964465
[TBL] [Abstract][Full Text] [Related]
18. The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients.
Davenport MS; Cohan RH
Radiol Clin North Am; 2017 Mar; 55(2):413-421. PubMed ID: 28126223
[TBL] [Abstract][Full Text] [Related]
19. Absence of Iodinated Contrast Hypersensitivity and Characterization of Gadolinium Utilization in an Interventional Pain Population.
Kalangara J; Lanier K; Beckworth WJ; Kuruvilla M
Pain Pract; 2021 Feb; 21(2):184-189. PubMed ID: 32898929
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
